Application of human body to evaluate the effect and safety of Plantago asiatica Extract from obese on the Improvement of Body Fat.
- Conditions
- Endocrine, nutritional and metabolic diseases
- Registration Number
- KCT0005731
- Lead Sponsor
- Bundang Jesaeng Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 90
1) Subject who voluntarily agree to participate and signs informed consent form
2) Aged more than 19 years and less less than 65 years, women and men
3) Those who have a body mass index (BMI) of 25kg/ bb m*2 or more and less than 30kg/m*2
4) Those who have waist circumference of more than 90cm for men and 85cm for women
5) Those who can follow the diet and exercise guidelines during the intervention period
1) Those who have taken or are likely to take medications that affect body weight, blood sugar, or lipids within one month of the first visit: appetite suppressants, diuresis, beta-blockers, contraceptives, hormone drugs, TCA agents, laxates, blood glucose depressants, lipid-lowering drugs, antidepressants, antidepressants
2) If you have,
? Uncontrolled hypertension
? Those who have been diagnosed with diabetes or are determined to need treatment, or who have fasting blood glucose level of 180 mg /dL or more
? Liver dysfunction or hepatobiliary disease
? Renal dysfunction
? Hyperthyroidism and hypofunction, Cushing's syndrome
? If you have a medical history of severe central nervous system disorder that require hospitalization or medication
? Those with severe cerebrovascular disease. However, dizziness If there is no medical history, it may be excluded at the discretion of the researcher.
? Malignant tumor, lung disease, musculoskeletal disease, immune system or inflammatory disease
? A person who complains of gastrointestinal disorders or severe gastrointestinal symptoms such as heartburn, indigestion or severe constipation.
3) Those who have experience in satellite type or ministerial resection surgery, for weight loss.
4) Those who have participated in commercial obesity programs or received calorific dietary treatment within three months of their first visit.
5) Those who have changed his or her weight by more than 5% within three months of their first visit.
6) Those who continue to exercise at high intensity.
7) Those who have good quality of his usual diet.
8) Those who have continuously consumed dietary supplements or herbal medicines affecting their weight, blood glucose, and lipids within one month of their first visit.
9) Those who have hypersensitivity to the test / placebo or ingredients or have experienced severe food allergic.
10) Participants in other human application research within 1 month of first visit.
11) Pregnant or lactating women or have plant to pregnant.
12) If the researcher deems inappropriate to participate in this study.
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Body fat improvement indicator
- Secondary Outcome Measures
Name Time Method Body fat related metabolic indicators